Anandamide Concentration-Dependently Modulates Toll-Like Receptor 3 Agonism or UVB-Induced Inflammatory Response of Human Corneal Epithelial Cells
Authors:
- Ágnes AngyalÁAÁgnes Angyal
- Zsófia PénzesZPZsófia Pénzes
- Shahrzad AlimohammadiShahrzad Alimohammadi
- Dorottya HorváthDHDorottya Horváth
- Lili TakácsLTLili Takács
- György VerebGVGyörgy Vereb
- Barbara ZsebikBarbara Zsebik
- Tamás BíróTBTamás Bíró
- Kinga Fanni TóthKTKinga Fanni Tóth
- Erika LisztesELErika Lisztes
- Balázs István TóthBTBalázs István Tóth
- Attila OláhAttila Oláh
Open Access
- 21 July 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (15) , 7776
Abstract
Photodamage-induced and viral keratitis could benefit from treatment with novel nonsteroid anti-inflammatory agents. Therefore, we determined whether human corneal epithelial cells (HCECs) express members of the endocannabinoid system (ECS), and examined how the endocannabinoid anandamide (AEA, N-arachidonoyl ethanolamine) influences the Toll-like receptor 3 (TLR3) agonism- or UVB irradiation-induced inflammatory response of these cells. Other than confirming the presence of cannabinoid receptors, we show that endocannabinoid synthesizing and catabolizing enzymes are also expressed in HCECs in vitro, as well as in the epithelial layer of the human cornea in situ, proving that they are one possible source of endocannabinoids. p(I:C) and UVB irradiation was effective in promoting the transcription and secretion of inflammatory cytokines. Surprisingly, when applied alone in 100 nM and 10 μM, AEA also resulted in increased pro-inflammatory cytokine production. Importantly, AEA further increased levels of these cytokines in the UVB model, whereas its lower concentration partially prevented the transcriptional effect of p(I:C), while not decreasing the p(I:C)-induced cytokine release. HCECs express the enzymatic machinery required to produce endocannabinoids both in vitro and in situ. Moreover, our data show that, despite earlier reports about the anti-inflammatory potential of AEA in murine cornea, its effects on the immune phenotype of human corneal epithelium may be more complex and context dependent.Keywords
Funding Information
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal (125053, 128034, 135938, 134235, 134993, 134725, 134791)
- Emberi Eroforrások Minisztériuma (EFOP-3.6.3-VEKOP-16-2017-00009)
- Pénzügyi Minisztérium (GINOP-2.3.2-15-2016-00050, GINOP-2.3.3-15-2016-00020)
- János Bolyai Research Scholarship (BO/00491/18)
- New National Excellence Program of the Ministry for Innovation and Technology (ÚNKP-20-5-DE-100, ÚNKP-20-5-DE-422)
This publication has 48 references indexed in Scilit:
- TRPV1 Involvement in Inflammatory Tissue Fibrosis in MiceThe American Journal of Pathology, 2011
- Δ9‐Tetrahydrocannabinol andN‐arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC‐1B cellsBritish Journal of Pharmacology, 2011
- Effect of basic fibroblast growth factor and cytochrome c peroxidase combination in transgenic mice corneal epithelial healing process after excimer laser photoablationClinical Ophthalmology, 2011
- Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cellsExperimental Eye Research, 2010
- Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonistPain, 2010
- Corneal transparency: Genesis, maintenance and dysfunctionBrain Research Bulletin, 2010
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- Finding of endocannabinoids in human eye tissues: Implications for glaucomaBiochemical and Biophysical Research Communications, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Pharmakologische Wertbestimmung von orientalischem Haschisch und Herba cannabis indicaeNaunyn-Schmiedeberg's Archives of Pharmacology, 1928